How to Convert Hepatitis B Positive to Negative: Latest Approaches in 2025

Have you or someone you care about received a hepatitis B positive diagnosis? If so, you’re likely wondering if there’s a way to convert that status to negative. This question brings many people to search for answers, and with good reason—hepatitis B affects over 296 million people worldwide, according to the World Health Organization.

I’ve spent considerable time researching this topic, and what I’ve discovered is both encouraging and nuanced. The landscape of hepatitis B treatment has evolved dramatically in 2025, with breakthrough therapies offering new hope for those seeking to clear the virus.

In this comprehensive guide, I’ll walk you through what it actually means to convert from hepatitis B positive to negative, the latest medical treatments available, cutting-edge research breakthroughs, and supportive approaches that might help along the way. My goal is to provide you with accurate, up-to-date information that can help you make informed decisions about your health journey.

Understanding Hepatitis B Status

Before diving into treatments and cures, it’s essential to understand what we mean by “hepatitis B positive” and what “converting to negative” actually entails from a medical perspective.

What Does “Hepatitis B Positive” Mean?

When healthcare providers say you’re “hepatitis B positive,” they’re typically referring to the presence of specific markers in your blood:

• Hepatitis B surface antigen (HBsAg): The primary marker indicating active hepatitis B infection
• Hepatitis B e-antigen (HBeAg): Often indicates high viral replication and infectivity
• Hepatitis B virus DNA (HBV DNA): Measures the amount of virus in your bloodstream

A person is considered to have chronic hepatitis B when the HBsAg remains detectable in the blood for more than six months after the initial infection.

What Does “Converting to Negative” Actually Mean?

Here’s where things get interesting—and where many misconceptions arise. In medical terms, there are different levels of “cure” for hepatitis B:

1. Virological suppression: Antiviral medications reduce the virus to undetectable levels in the blood, but the virus remains in the liver cells.
2. Functional cure: HBsAg disappears from the blood and remains undetectable for at least six months after stopping treatment, with or without antibody development. This is the current goal of most advanced treatments.
3. Complete elimination (sterilizing cure): The virus is completely removed from the body, including all viral DNA from liver cells. This is extremely rare and not yet achievable with current treatments for most patients.

According to a 2025 study published in Nature Scientific Reports, a functional cure is defined as “the sustained disappearance of HBsAg (lasting more than 6 months after treatment has ended) with or without seroconversion to anti-HBs.”

It’s important to understand that when most medical professionals talk about “converting from positive to negative,” they’re typically referring to achieving a functional cure rather than complete elimination of the virus.

Natural Clearance: Why Some People Clear the Virus Naturally

Interestingly, about 90% of adults who contract hepatitis B will clear the virus naturally without treatment. Their immune systems successfully fight off the infection, and they develop antibodies that provide lifelong immunity.

However, for those who develop chronic hepatitis B (particularly those infected at birth or in early childhood), natural clearance is much rarer. The annual rate of spontaneous HBsAg clearance in chronic cases is only about 0.5-1%.

Factors that influence natural clearance include:

• Age at infection (younger age = lower clearance rates)
• Immune system strength
• Viral genotype
• Genetic factors

Conventional Medical Treatments

For those with chronic hepatitis B, several FDA-approved treatments can help suppress the virus and, in some cases, lead to functional cure.

Nucleos(t)ide Analogues (NAs)

These oral antiviral medications work by inhibiting HBV replication:

• Entecavir (Baraclude)
• Tenofovir disoproxil fumarate (Viread)
• Tenofovir alafenamide (Vemlidy)

These medications are highly effective at suppressing the virus, with minimal side effects and low resistance rates. However, they typically require long-term, often lifelong, treatment.

The success rate for viral suppression with these medications is impressive—over 95% of patients achieve undetectable HBV DNA levels. However, HBsAg loss (functional cure) occurs in only about 1-2% of patients per year.

Interferon Therapy

Interferon-based treatments work differently by boosting the immune system’s response to the virus:

• Pegylated interferon alfa-2a (Pegasys)

Unlike NAs, interferon therapy is given for a finite period (usually 48 weeks) and has a higher chance of achieving HBsAg loss. However, it comes with more side effects and is not suitable for all patients.

The functional cure rate with interferon is approximately 3-7% in HBeAg-positive patients and 3% in HBeAg-negative patients.

Combination Therapies

Some studies have explored combining NAs with interferon to improve outcomes. According to Contagion Live, a combination of imdusiran (an RNAi therapeutic) and pegylated interferon alfa-2a achieved a functional cure in 50% of chronic hepatitis B patients in recent trials—a remarkable improvement over traditional therapies.

Breakthrough Research and Clinical Trials (2025)

This is where the most exciting developments are happening. Several cutting-edge approaches are showing promise for achieving higher rates of functional cure.

Gene Editing Approaches

In March 2025, the FDA cleared the first-ever in vivo gene-editing therapy for chronic hepatitis B to enter clinical trials in the United States. According to CRISPR Medicine News, PBGENE-HBV targets the root cause of chronic HBV infection.

“Our therapy is designed to deliver a cure. We measure this through a regulatory endpoint called functional cure where the two key viral markers, HBV DNA and HBsAg, are no longer detectable in the blood,” explained the researchers.

This approach uses CRISPR technology to target and cut the viral DNA that has integrated into liver cells, potentially eliminating the source of viral persistence.

Therapeutic Vaccines

Unlike preventive vaccines, therapeutic vaccines aim to boost the immune response in people already infected with hepatitis B.

TherVacB, a therapeutic vaccine, is scheduled to begin clinical trials in January 2025 in Europe and Africa. This approach combines protein and vector vaccines to stimulate both antibody and T-cell responses against the virus.

The goal is to help the immune system recognize and clear infected liver cells, potentially leading to functional cure without the need for lifelong medication.

RNA-Based Treatments

RNA interference (RNAi) therapeutics represent another promising approach. These medications target specific RNA molecules involved in viral replication.

A 2025 study published in PubMed Central notes that “new therapeutic strategies aim to achieve long-lasting viral suppression with shorter treatment durations while also restoring the body’s immune response.”

Imdusiran is one such RNAi therapeutic that has shown impressive results, especially when combined with interferon therapy.

Monoclonal and Polyclonal Antibodies

In August 2024, the FDA approved GIGA-2339, the first recombinant human polyclonal antibody treatment for HBV, to begin clinical trials. According to Contagion Live, this approach offers a new mechanism to target the virus.

These antibodies bind to viral particles in the bloodstream, preventing them from infecting new liver cells and potentially helping to clear the virus from the body.

Lifestyle and Supportive Approaches

While medical treatments are the primary path to converting hepatitis B positive to negative, certain lifestyle approaches can support liver health and potentially improve treatment outcomes.

Supporting Liver Health

Your liver is remarkably resilient, but giving it extra support during hepatitis B treatment makes sense:

• Maintain a healthy weight: Excess weight can contribute to fatty liver disease, adding stress to an already challenged liver.
• Eat a liver-friendly diet: Focus on fruits, vegetables, whole grains, and lean proteins. Some research suggests that cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) may have liver-protective properties.
• Stay hydrated: Adequate water intake helps the liver function optimally.
• Exercise regularly: Moderate exercise can help reduce liver fat and improve overall liver function.

What to Avoid

Certain substances can stress the liver and potentially interfere with treatment:

• Alcohol: Even moderate alcohol consumption can exacerbate liver damage in people with hepatitis B.
• Tobacco: Smoking has been linked to increased liver fibrosis progression in viral hepatitis.
• Certain medications and supplements: Always consult with your healthcare provider before taking any over-the-counter medications or supplements, as some can be toxic to the liver.

Regular Monitoring

Regular check-ups and blood tests are essential for:

• Monitoring viral load and liver function
• Detecting any treatment side effects early
• Adjusting treatment as needed
• Assessing progress toward functional cure

Factors Affecting Treatment Success

Not everyone responds to hepatitis B treatments in the same way. Several factors can influence your chances of converting from positive to negative:

Viral Factors

• Viral genotype: There are at least 10 different genotypes of HBV (A through J), and some respond better to certain treatments than others.
• Viral load: Generally, lower baseline viral loads are associated with better treatment outcomes.
• Viral mutations: Certain mutations in the HBV genome can affect treatment response.

Host Factors

• Age: Younger patients typically have better treatment outcomes than older patients.
• Gender: Some studies suggest that women may have slightly better rates of HBsAg clearance than men.
• Immune status: A healthy, robust immune system is crucial for clearing the virus.
• Genetic factors: Certain genetic variations can influence how well a person responds to treatment.

According to a 2025 study in Science Direct, researchers are making progress in identifying factors that predict successful functional cure, which could help tailor treatments to individual patients in the future.

Common Misconceptions and Facts

There’s a lot of misinformation about hepatitis B treatment, particularly online. Let’s address some common misconceptions:

Misconception: Herbal remedies can cure hepatitis B

Fact: While some herbs may have liver-protective properties, there is no scientific evidence that any herbal remedy can eliminate the hepatitis B virus. Always discuss supplements with your healthcare provider, as some can actually harm the liver.

Misconception: Once you start treatment, you can stop when you feel better

Fact: Stopping antiviral treatment prematurely can lead to viral rebound and potentially severe flares of hepatitis. Treatment decisions should always be made in consultation with a healthcare provider.

Misconception: A negative HBV DNA test means you’re cured

Fact: Undetectable viral DNA is an excellent sign that treatment is working, but it doesn’t necessarily mean the virus is eliminated. HBsAg must also be negative for at least six months after stopping treatment to be considered a functional cure.

Misconception: Hepatitis B always leads to liver cancer

Fact: While chronic hepatitis B increases the risk of liver cancer, effective treatment and monitoring significantly reduce this risk. Many people with well-managed hepatitis B never develop serious liver complications.

The Future of Hepatitis B Treatment

The hepatitis B treatment landscape is evolving rapidly. A breakthrough discovery announced in February 2025 revealed a compound that successfully disrupted the virus’s ability to infect human liver cells in laboratory settings.

According to Novotech CRO’s 2025 report, research is increasingly focused on achieving a functional cure through RNA-based treatments, monoclonal antibodies, and gene therapies.

The goal of these new approaches is to achieve what current treatments rarely accomplish: a durable functional cure without the need for lifelong medication.

Conclusion

Converting from hepatitis B positive to negative—achieving a functional cure—is becoming increasingly possible with advances in medical science. While conventional treatments like nucleos(t)ide analogues and interferon have limited success rates for functional cure, emerging therapies like gene editing, therapeutic vaccines, and RNA-based treatments offer new hope.

If you’re living with hepatitis B, the most important steps you can take are:

1. Work closely with healthcare providers specializing in liver disease
2. Adhere to prescribed treatments
3. Attend regular monitoring appointments
4. Support your liver health through lifestyle choices
5. Stay informed about new treatment options

Remember that even without achieving a functional cure, modern treatments can effectively suppress the virus and prevent liver damage, allowing most people with hepatitis B to live normal, healthy lives.

The future looks promising, with multiple innovative approaches in clinical trials that could revolutionize hepatitis B treatment in the coming years. While we may not yet have a universal cure, we’re closer than ever before.

Frequently Asked Questions